• Home
  • Stocks
  • Sun Pharmaceutical Industries Fundamental Analysis
  • Sun Pharmaceutical Industries Fundamental Analysis

Sun Pharmaceutical Industries fundamental analysis

SUNPHARMA

HealthcareLarge

1704.4

2.30 (0.14%)
Last updated on 4 Feb, 2026 | 15:53 IST
alert_iconwatchlist_icon
BUYSELL

alert_iconThe current prices are delayed, login to your account for live prices

Sun Pharmaceutical Industries Fundamentals

P/E Ratio

35.81

P/B Ratio

4.81

Div. Yield

0.98

Sector P/E

65.66

Sector P/B

1.41

Sec. Div. Yield

0.59

Sun Pharmaceutical Industries Fundamentals is currently trading with a P/E Ratio of 35.81, compared to the sector average of 65.66. Its P/B Ratio stands at 4.81, while the sector’s is 1.41. In terms of returns, the stock offers a Dividend Yield of 0.98%, which is than the sector’s 0.59%.

Sun Pharmaceutical Industries Score Card

  • price_icon
    Price

    Attractive

  • chart_icon
    Growth

    Average

  • quality_check
    Quality

    Good

  • quality_check
    Management

    Poor

On its scorecard, Sun Pharmaceutical Industries reflects: Price – Attractive, Growth – Average, Quality – Good, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.